No abstract available
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / adverse effects*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal, Humanized
-
Aptamers, Nucleotide / administration & dosage
-
Aptamers, Nucleotide / adverse effects
-
Bevacizumab
-
Cause of Death
-
Hemorrhage / etiology
-
Hemorrhage / mortality*
-
Humans
-
Macular Degeneration / drug therapy*
-
Myocardial Infarction / etiology
-
Myocardial Infarction / mortality*
-
Photochemotherapy / adverse effects
-
Ranibizumab
-
Risk Factors
-
Stroke / etiology
-
Stroke / mortality*
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Aptamers, Nucleotide
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
pegaptanib
-
Bevacizumab
-
Ranibizumab